Correspondence 0001104659-25-009409 from MUSTANG BIO, INC. (MBIO) (CIK 0001680048) (MBIO)
MUSTANG BIO, INC. (MBIO) (CIK 0001680048)
Date: Feb. 5, 2025 · CIK: 0001680048 · Accession: 0001104659-25-009409
AI Filing Summary & Sentiment
File numbers found in text: 333-284299
Letter
Mustang Bio, Inc.
377 Plantation Street
Worcester, Massachusetts 01605
VIA EDGAR
February 5, 2025
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Tim Buchmiller
Re: Mustang Bio, Inc.
Registration Statement on Form S-1 (Reg. No. 333-284299)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mustang Bio, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) so that the Registration Statement will be declared effective as of 5:15 p.m. Eastern time, on February 5, 2025, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or Alexander Yarbrough, both of whom are attorneys at the Company’s outside legal counsel, Troutman Pepper Locke LLP, to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Yarbrough at (704) 998-4077.
Thank you for your assistance in this matter.
Very truly yours,
Mustang Bio, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Mustang Bio, Inc.
377 Plantation Street
Worcester, Massachusetts 01605
VIA EDGAR
February 5, 2025
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Tim Buchmiller
Re:
Mustang Bio, Inc.
Registration Statement on Form S-1 (Reg. No. 333-284299)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Mustang Bio, Inc. (the “Company”) hereby requests that the Securities and Exchange
Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form
S-1 (the “Registration Statement”) so that the Registration Statement will be declared effective as of 5:15 p.m. Eastern
time, on February 5, 2025, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or Alexander Yarbrough,
both of whom are attorneys at the Company’s outside legal counsel, Troutman Pepper Locke LLP, to orally modify or withdraw this
request for acceleration.
Once the Registration Statement
has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Yarbrough at (704) 998-4077.
Thank you for your assistance
in this matter.
Very truly yours,
Mustang Bio, Inc.
/s/ Manuel Litchman
Name:
Manuel Litchman, M.D.
Title:
President, Chief Executive Officer and Director
cc (via email):
Rakesh Gopalan, Troutman Pepper Locke LLP
Alexander T. Yarbrough, Troutman Pepper Locke LLP
Robert F. Charron, Ellenoff Grossman & Schole LLP
John J. Hart, Ellenoff Grossman & Schole LLP